Direct discovery · Medicine · Biology · Chemistry
Machine learning identifies abaucin as a targeted antibiotic lead
A targeted antibiotic lead against Acinetobacter baumannii with mechanistic and mouse-model follow-up.
Summary
The Nature Chemical Biology paper trained a neural network on Acinetobacter baumannii growth-inhibition data, screened for structurally new active molecules and identified abaucin. The paper reports narrow-spectrum activity, a mechanism involving LolE and control of infection in a mouse wound model.
AI role
Screened for structurally new active molecules after learning from bacterial growth-inhibition data.
Narrative role
Abaucin adds a second antibiotic-discovery example where the AI output is tied to a concrete lead and biological validation rather than just virtual screening.
Caveat
The result remains a research lead; clinical safety and efficacy are separate downstream questions.